I have had a lot of problems with my blood works and elevated since I have had this shot; Below the injection site I have a merge area that slower, it's red and it's warm and very its very tinder to touch and it's worsen like that until I get the shot; Below the injection site I have a merge area that slower, it's red and it's warm and very its very tinder to touch and it's worsen like that until I get the shot; Below the injection site I have a merge area that slower, it's red and it's warm and very its very tinder to touch and it's worsen like that until I get the shot; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 58-year-old female patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 23Dec2022 as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 58 years for covid-19 immunisation. The patient's relevant medical history included: "Diabetes" (ongoing); "Blood pressure high" (unspecified if ongoing); "High cholesterol" (unspecified if ongoing). Concomitant medication(s) included: JARDIANCE; METFORMIN; HUMALOG; TRULICITY; ATORVASTATIN taken for blood cholesterol. Vaccination history included: Covid-19 vaccine (Dose 1, Manufacturer unknown), for COVID-19 immunization; Covid-19 vaccine (Dose 2, Manufacturer unknown), for COVID-19 immunization; Covid-19 vaccine (Dose 3, Manufacturer unknown), for COVID-19 immunization. The following information was reported: ERYTHEMA (non-serious), FEELING HOT (non-serious), TENDERNESS (non-serious) all with onset Dec2022, outcome "unknown" and all described as "Below the injection site I have a merge area that slower, it's red and it's warm and very its very tinder to touch and it's worsen like that until I get the shot"; BLOOD TEST ABNORMAL (non-serious) with onset Dec2022, outcome "unknown", described as "I have had a lot of problems with my blood works and elevated since I have had this shot". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of blood test abnormal, erythema, feeling hot, tenderness.  Additional information:Now Below the injection site patient had a merge area that slower, it was red and it was warm and very it was very tinder to touch and it's worsen like that until she got the shot. When paraphrased the concern: Consumer stated, Yes, It was below the injection site it was not at the injection site, it was below it. When probed to clarify if patient needs any assistance regarding it or wants to report it: Consumer stated, she guess just to report a side effect. Patient had a lot of problems with her blood works and elevated since she had this shot. On other medications, consumer stated, she took Insulin and it was Humalog and then she took Jardiance, metformin, Trulicity. She can't think of the name of the blood pressure it starts with an O. I take blood pressure medication and then it's cholesterol medication is atorvastatin (Captured in tab). I do know that one. Prior Vaccination (Within the Four weeks): Consumer stated, No, nothing. Treatment (Adverse Event): Consumer stated, she has been taking Tylenol and then been taking extra insulin trying to get her sugar back down (Further clarifications unknown). The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.